Stem Cell Veto Could Hurt U.S. Competitiveness, Says William Caldwell, CEO of Advanced Cell Technology

Caldwell's company is working on stem-cell-based therapies for macular degeneration.  Bloomberg TV interviewed him this week for his views. Watch here.
June 22, 2007
Caldwell's company is working on stem-cell-based therapies for macular degeneration.  Bloomberg TV interviewed him this week for his views. Watch here.

About the Author

pharmamanufacturing

pharmamanufacturing

Sign up for our eNewsletters
Get the latest news and updates

Related

Fujifilm Biotechnologies to leverage downstream purification system at UK site
Fujifilm’s modular, scalable manufacturing takes shape amid complex global supply chain
2026 Manufacturing Pharma Trends for Life Sciences
Sponsored
2026 AI Trends in Life Sciences
Sponsored